RAID

Quote
Anonymous said:
Sunshine, London doesn't give a flying shit about anything other than the final number. You better hit it, or you're gone. Forecast allows for changes along the way, but at the end of the day, it's the promised number they expect. Just try lowering your forecast in the 4th quarter, and see what the Brits do.
Click to expand...

They built in a degree of market loss in $$ for the year. If RB still beats that number despite losing CVS and United, then it doesn't matter. That's what London cares about, whether or not we beat the forecast that already had loss built in. Only time will tell. All we can do is keep what we have that is covered. I know my doctors aren't writing Zubsolv because they think it is a superior product, that's for sure. They are being forced to write it.
 






the patients are being forced to change, then they fail on zubsolv, and they ask to come back to Film. we will have ups and downs. the bigger problem is more are being put on mono and that is the real challenge to treatment. orexo is creating a mess, and the doctors do not appreciate it. the product is not on a par with suboxone film, and we will overcome this.
 






Anonymous said:
That's why they announce quarterly target earnings dumbass. If a company isn't performing they adjust their forecast, ie. Orexo. You really think an earnings forecast is for an entire year without checks and balances? Stock and shareholder responsibilities? And you really think RB solutions will not adjust their third and fourth quarter forecasts with the managed care loss? Talk about an idiot.
Click to expand...


This post is 100% correct. You can look for analysts to peel back on RBS before the end of the week, the earnings forecast will change dramatically and the third and fourth quarter revisions are being made right now.
 






Orexo has already reached similar conditions with Medimpact from January 2014.


CVS Caremark
Total lives covered=85,100,000
Market share=11,99%

MedImpact Healthcare Systems, Inc.
Total lives covered=32,000,000
Market share=4,51%
 




































Anonymous said:
P.S. My doctors really love how you created individualized snorting packs with your "revolutionary" packaging.
Click to expand...

As much hating is going on at Reckitt between all the "CL's" how can you work without constant distractions everyday LMFAO!!! We will keep getting our MC wins and you guys can keep pointing fingers at each other, your site is a riot !
 






Anonymous said:
As much hating is going on at Reckitt between all the "CL's" how can you work without constant distractions everyday LMFAO!!! We will keep getting our MC wins and you guys can keep pointing fingers at each other, your site is a riot !
Click to expand...

You are getting MC wins (United) because you are offering your drug for pennies on the dollar as you missed your 2013 financial projections by a mile. It is called desperation. BTW, how are those promised bonuses you were supposed to get this month?

What do you think will happen next year when those contracts need to be renegotiated? You will jack up the price as no company can give away drugs, and your cost will be comparable to ours. Since the Film is a superior product and the costs will be comparable, what do you think will happen?
 






Anonymous said:
You are getting MC wins (United) because you are offering your drug for pennies on the dollar as you missed your 2013 financial projections by a mile. It is called desperation. BTW, how are those promised bonuses you were supposed to get this month?

What do you think will happen next year when those contracts need to be renegotiated? You will jack up the price as no company can give away drugs, and your cost will be comparable to ours. Since the Film is a superior product and the costs will be comparable, what do you think will happen?
Click to expand...

^^^^^^^^^^^^^^^
This.

Have you seen your own board, Orexo rep? That place is a dumpster fire. Your company had to borrow more $$ from investors bc Zubsolv is doing so poorly. So get off our board and concentrate on trying to sell doctors on your inferior product. One more thing; tell your fellow reps to stop leaving sales items with hand-written notes all over them. It's kinda illegal.
 






Anonymous said:
^^^^^^^^^^^^^^^
This.

Have you seen your own board, Orexo rep? That place is a dumpster fire. Your company had to borrow more $$ from investors bc Zubsolv is doing so poorly. So get off our board and concentrate on trying to sell doctors on your inferior product. One more thing; tell your fellow reps to stop leaving sales items with hand-written notes all over them. It's kinda illegal.
Click to expand...


Our board has two threads devoted to Zubsolv. Over half the posts in both are from Reckitt reps and spare everyone CL please, it's embarrassing. You all keep the in fighting going it's entertainment for us.
 






You know what is sad...not entertains at all? Back in the day the main story was truly about helping patients!!! Get back to workALL OF YOU!!! This disease space is in epidemic proportions and if you take on the role of CL/ rep, do the job justice!! Or get out!
 






Stay focused and sell treatment! Zub is not going to go far, it doesn't work and not even cvs won't continue to pay for it if the patients have to go up to 3 instead of 2. Generics are the problem. Grow your market. Orexo certainly cant do that, they don't know jack about this disease state and look foolish in the offices.
 






Anonymous said:
Stay focused and sell treatment! Zub is not going to go far, it doesn't work and not even cvs won't continue to pay for it if the patients have to go up to 3 instead of 2. Generics are the problem. Grow your market. Orexo certainly cant do that, they don't know jack about this disease state and look foolish in the offices.
Click to expand...


I disagree, sales is sales and from what I've read RB does not have the sharpest tools in the shed. Aren't you all mostly social workers and counselors? You were lucky to have the only product in the disease state. Some of you call it disease space? WTF is that ? Go to a real Pharma company, if you said that they would fire your ass on the spot.

There will be more coming to market in different delivery systems, just sell what you have as we will and good luck to all. Just remember it's a job you are not a doctor saving lives so get your ass off that horse.
 






Anonymous said:
Stay focused and sell treatment! Zub is not going to go far, it doesn't work and not even cvs won't continue to pay for it if the patients have to go up to 3 instead of 2. Generics are the problem. Grow your market. Orexo certainly cant do that, they don't know jack about this disease state and look foolish in the offices.
Click to expand...

i learned a long time ago to never underestimate your competition, just becuase they are down today, doens't mean they will be down tomorrow. Things change, people change. Worry about growing our business and telling the Drs why our product is superior while we still have access. Sell, sell, sell.
 






Anonymous said:
I disagree, sales is sales and from what I've read RB does not have the sharpest tools in the shed. Aren't you all mostly social workers and counselors? You were lucky to have the only product in the disease state. Some of you call it disease space? WTF is that ? Go to a real Pharma company, if you said that they would fire your ass on the spot.

There will be more coming to market in different delivery systems, just sell what you have as we will and good luck to all. Just remember it's a job you are not a doctor saving lives so get your ass off that horse.
Click to expand...

I have to agree with you regarding the term "disease space." I absolutely refuse to use that term as it isn't even proper English, not to mention it makes us sound ridiculous. Unfortunately this is an example of sales people trying to sound clinical, but doing a piss poor job of it!
 






Anonymous said:
i learned a long time ago to never underestimate your competition, just becuase they are down today, doens't mean they will be down tomorrow. Things change, people change. Worry about growing our business and telling the Drs why our product is superior while we still have access. Sell, sell, sell.
Click to expand...


I agree but, don't tell. Show them why it's superior you have a lot more street cred with the docs.
 






Anonymous said:
I have to agree with you regarding the term "disease space." I absolutely refuse to use that term as it isn't even proper English, not to mention it makes us sound ridiculous. Unfortunately this is an example of sales people trying to sound clinical, but doing a piss poor job of it!
Click to expand...

This is so spot on. I have to agree with this post. The old model set up by your golden grandpa is OUTDATED and a legal nightmere. You are not "clinical" - you are a sales fucking force. And you don't get your payouts based on the amount of "treatment" you sell - get it???

BTW your access is slipping away regardless of whose is the best product because your psychotic MC director (whose power trip days are seriously numbered) has destroyed RB's reputation with every plan out there!!!!. Eat that
 






Top Bottom
Back
Quote